CLDN5 and rheumatoid arthritis: Moreover, treatment with Infliximab significantly increased claudin-5 expression compared to vehicle treated RA animals (RA: 0,43 ± 0,07, n = 10 vs. RA Infliximab: 1,04 ± 0,14, n = 11; P = 0.001).